Anne Freimoser-Grundschober
0000-0001-5715-3639
4 papers found
Refreshing results…
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
p95HER2–T cell bispecific antibody for breast cancer treatment
Missing publications? Search for publications with a matching author name.